Nuclear Medicine in Times of COVID-19: How Radiopharmaceuticals Could Help to Fight the Current and Future Pandemics

Nuclear Medicine in Times of COVID-19: How Radiopharmaceuticals Could Help to Fight the Current and Future Pandemics

The emergence and global spread of COVID-19, an infectious disease caused by the novel coronavirus SARS-CoV-2, has resulted in a continuing pandemic threat to global health. Nuclear medicine techniques can be used for functional imaging of (patho)physiological processes at the cellular or molecular...

Full description

Bibliographic Details
Main Authors: Felix Neumaier, Boris D. Zlatopolskiy, Bernd Neumaier
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Pharmaceutics
Subjects:
molecular imaging of SARS-CoV-2
radionuclide therapy of COVID-19
PET-based antiviral drug development
diagnostic radionuclides
therapeutic radionuclides
positron emission tomography (PET)
Online Access:https://www.mdpi.com/1999-4923/12/12/1247

Internet

https://www.mdpi.com/1999-4923/12/12/1247

Similar Items